ATNM
AMEX · Biotechnology
Actinium Pharmaceuticals Inc
$1.15
-0.01 (-0.86%)
Open$1.19
Previous Close$1.16
Day High$1.19
Day Low$1.15
52W High$30.10
52W Low$15.80
Volume—
Avg Volume567.9K
Market Cap35.88M
P/E Ratio—
EPS$-0.05
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
+3,040.0% upside
Current
$1.15
$1.15
Target
$36.11
$36.11
$23.47
$36.11 avg
$39.96
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 5.34M | 4.99M | 5.52M |
| Net Income | -1,194,048 | -1,193,914 | -1,096,791 |
| Profit Margin | -22.4% | -23.9% | -19.9% |
| EBITDA | -1,875,472 | -1,575,968 | -1,727,883 |
| Free Cash Flow | -941,082 | -691,464 | -912,603 |
| Rev Growth | +5.7% | +20.9% | +5.2% |
| Debt/Equity | 0.64 | 0.67 | 0.80 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |